Chronic Pain Self-Management With Integrative Yoga Therapy (IYT)

Chronic Pain Clinical Trial

Official title:

Evaluating Community-Based Pain Self-Care Using Integrative Yoga Therapy (IYT): Quasi Experimental Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04313426
• Other study ID #: AU05
• Status: Completed
• Phase: N/A
• Start date: October 30, 2019
• Est. completion date: February 28, 2020

Study information

• Verified date: March 2020
• Source: Aarogyam UK
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study was to evaluate efficacy of chronic pain self-management program in community settings to adopt Integrative Yoga Therapy (IYT).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: February 28, 2020
• Est. primary completion date: November 6, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Older than 18 years old.

• having a chronic pain of more than 3 months of duration, no matter the aetiology.

• Capable of understanding and giving written informed consent.

• Significant levels of distress and disability related to the pain at the beginning of treatment

Exclusion Criteria:

• Intelectual disability or cognitive impairment

• Planning to move out of area

• Serious mental illness

• Drugs or substance abuse in the last 6 months

• Post surgery or scheduled for surgery

• Cancer related pain

Related Conditions & MeSH terms

• Chronic Nonmalignant Pain
• Chronic Pain

Intervention

Other:
• Integrative Yoga Therapy
Integrative Yoga Therapy included personalised yoga therapy sessions including their standard care, yoga movements, relaxation, meditation, breathing practices and yoga counselling sessions.

Locations

Country	Name	City	State
United Kingdom	Karyalaya	Leicester

Sponsors (3)

Lead Sponsor	Collaborator
Aarogyam UK	Hindu Swayamsevak Sangh (UK), Leicester Ageing Together

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain Intensity	Analogical Visual Scale from 0 to 10 scores where 0 describes no pain and 10 worst pain.	From baseline to 6-week post intervention
Secondary	Anxiety and Depression	Hospital Anxiety and Depression Scale (HADS). 14 item, 7 each of anxiety and depression. Each item score between 0-3.	From baseline to 6-week post intervention
Secondary	Satisfaction with the treatment	Satisfaction with the treatment (CRES-4) 4 questions.	From Baseline to 6-week post intervention
Secondary	General Quality of Life	Nottingham Health Profile score between 0 to 100 where 0 is best and 100 is worst	From baseline to 6-week post intervention